bleeding from bone wounds in orthopedic surgery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with bone wounds requiring hemostasis. 2. Understand the trial purpose, participate voluntarily and sign the informed consent form
Exclusion criteria
Exclusion criteria: 1. Subjects with severe infection of bone wounds. 2. Subjects with severe coagulation dysfunction. 3. Subjects with known hypersensitivity to polyethylene glycol and sodium carboxymethyl cellulose. 4. This product shall not be used if intraoperative hemostasis is needed and inhibition of new bone formation is required simultaneously. 5. Subjects who are considered ineligible to participate in this clinical trial by the investigator for any other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective hemostasis rate within 3 minutes; | — |
Secondary
| Measure | Time frame |
|---|---|
| Bone wax usage;Rate of grade A incision healing;Bone healing rate; | — |
Countries
China
Contacts
Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine